搜索临床试验以:HDR 2 分数
总计104277个结果
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversity of Witwatersrand, South Africa; PD Hinduja Hospital and Medical Research Centre,... 和其他合作者完全的
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
Directed Systems LimitedUniversity Hospital Birmingham NHS Foundation Trust; Innovate UK完全的
-
Beth Israel Medical CenterSt. Luke's-Roosevelt Hospital Center撤销
-
Sahlgrenska University Hospital, Sweden尚未招聘胰腺癌 | 手术 | 转移 | 免疫抑制
-
Circassia LimitedCetero Research, San Antonio; Adiga Life Sciences, Inc.完全的
-
Centre Hospitalier Universitaire Dijon招聘中
-
Circassia LimitedQuintiles, Inc.完全的
-
Circassia LimitedAdiga Life Sciences, Inc.完全的
-
British Columbia Cancer AgencyBC Cancer Foundation主动,不招人
-
Puma Biotechnology, Inc.终止转移性宫颈癌 | 激素受体阳性、HER2 阴性的转移性乳腺癌西班牙, 以色列, 美国, 塞尔维亚, 法国, 爱尔兰, 意大利
-
HDT BioKaiser Permanente; Rainier Clinical Research Center; C3 Research Associates主动,不招人
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Amsterdam UMC, location VUmcUMC Utrecht; Catharina Ziekenhuis Eindhoven; Academisch Medisch Centrum - Universiteit van Amsterdam... 和其他合作者完全的
-
Billings ClinicHealing Dimensions, ACC完全的
-
University of BirminghamEuropean Commission; HUR Labs未知
-
Assistance Publique - Hôpitaux de Paris完全的FGFR3-TACC3 融合的复发性 IDHwt 胶质瘤 | 具有 FGFR1-TACC1 融合的复发性 IDHwt 胶质瘤法国
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Diagnostic Medical SystemsUniversity Hospital, Montpellier未知
-
American Academy of PediatricsUniversity of North Carolina, Chapel Hill; Thrasher Research Fund; RTI International; Saving Lives... 和其他合作者完全的
-
Korean Hemodialysis Study GroupBoryung Pharmaceutical Co., Ltd未知